N4P — N4 Pharma Balance Sheet
0.000.00%
Last trade - 00:00
- £2.28m
- £0.99m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.793 | 0.966 | 3.56 | 1.78 | 1.92 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.277 | 0.088 | 0.255 | 0.551 | 0.21 |
Prepaid Expenses | |||||
Total Current Assets | 1.07 | 1.07 | 3.83 | 2.34 | 2.17 |
Long Term Investments | |||||
Total Assets | 1.07 | 1.07 | 3.83 | 2.34 | 2.17 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.19 | 0.078 | 0.169 | 0.213 | 0.078 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.19 | 0.078 | 0.169 | 0.213 | 0.078 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 0.88 | 0.987 | 3.66 | 2.13 | 2.09 |
Total Liabilities & Shareholders' Equity | 1.07 | 1.07 | 3.83 | 2.34 | 2.17 |
Total Common Shares Outstanding |